AstraZeneca first quarter sales fall short as Nexium tumbles
AstraZeneca Plc nudged up its forecast for 2008 earnings on Thursday, but sales of ulcer pill Nexium and other key drugs in the first quarter were weaker than hoped for, knocking its shares. "The sales trends of most of the leading products were below wha